Most Recent
GSK defeats challenge to breakthrough RSV vaccine patent
Intellectual Property 2018-11-26 9:39 pm By Cat Fredenburgh

GlaxoSmithKline has won approval for a patent for a vaccine to prevent a common respiratory virus affecting infants, beating out a challenge from a rival that has developed a competing vaccine.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

  1. Pages:
  3. 1
  4. 2